APA (7th ed.) Citation

Langlois, J., Lange, S., Ebeling, M., Macnair, W., Schmucki, R., Li, C., . . . Keaney, J. (2024). Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. Journal of Neuroinflammation, 21(1), 1. https://doi.org/10.1186/s12974-024-03267-5

Chicago Style (17th ed.) Citation

Langlois, Julie, et al. "Fenebrutinib, a Bruton's Tyrosine Kinase Inhibitor, Blocks Distinct Human Microglial Signaling Pathways." Journal of Neuroinflammation 21, no. 1 (2024): 1. https://doi.org/10.1186/s12974-024-03267-5.

MLA (9th ed.) Citation

Langlois, Julie, et al. "Fenebrutinib, a Bruton's Tyrosine Kinase Inhibitor, Blocks Distinct Human Microglial Signaling Pathways." Journal of Neuroinflammation, vol. 21, no. 1, 2024, p. 1, https://doi.org/10.1186/s12974-024-03267-5.